Minor Use Minor Species Development of Drugs (R01)
Food and Drug Administration
Free. Verify your email, then we send one reminder only.
- Posted
- Dec 17, 2025
- Amount
- $250,000
- Closes
- Jan 29, 2027 (in 152 days)
Similar opportunities open now
- Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)Same funderOpenFood and Drug AdministrationCloses May 2028Up to $900K
- Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)Same funderOpenFood and Drug AdministrationCloses Feb 2028Up to $600K
- Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Jan 2028Up to $200K
- Animal and Veterinary Innovation Centers (U18)Same funderOpenFood and Drug AdministrationCloses May 2028Up to $1.3M
- Vet-LIRN Capacity-Building Project and Equipment Grants (U18)Same funderOpenFood and Drug AdministrationCloses Sep 2028Up to $2.5M
Classification and identifiers
- Solicitation number
- PAR-24-216
- Assistance listing (CFDA)
- 93.103
Amount
$250,000
Who can apply
Public colleges and universities and Local government agencies can all apply here. Check the eligibility details below to see if your organization fits.
• Faith-based or Community-based Organizations• Regional Organizations• Non-domestic (non-U.S.) Entities (Foreign Organizations)…
About this opportunity
This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS). The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs. Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants. The organization (or applicant) seeking approval of the new animal drug und...